UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009778
Receipt number R000002157
Scientific Title A prospective randomized study of "covered" vs "uncovered" metallic stents for the management of biliary stricture by unresectable pancreatic cancer.
Date of disclosure of the study information 2013/01/14
Last modified on 2014/02/19 09:15:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective randomized study of "covered" vs "uncovered" metallic stents for the management of biliary stricture by unresectable pancreatic cancer.

Acronym

"Covered" vs "uncovered" metallic stents for biliary stricture by unresectable pancreatic cancer.

Scientific Title

A prospective randomized study of "covered" vs "uncovered" metallic stents for the management of biliary stricture by unresectable pancreatic cancer.

Scientific Title:Acronym

"Covered" vs "uncovered" metallic stents for biliary stricture by unresectable pancreatic cancer.

Region

Japan


Condition

Condition

Biliary stricture caused by unresectable pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of covered metallic stent (CMS) and uncovered metallic stent (UMS)

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

duration until stent dysfunction

Key secondary outcomes

1) overall survival
2) incidence of side effect


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Covered metallic stent (CMS)

Interventions/Control_2

Uncovered metallic stent (UMS)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Pancreatic head cancer with biliary stricture
2) Pathological confirmation is essential.
3) Stricture of bile duct is middle to lower common bile duct.
4) Clinical stage (UICC) is more than stage 2b.
5)Informed consent is essential.

Key exclusion criteria

1) PS > 4.
2) Severe complication of another organ.
3) A patient who gives no written IC.
4) A participating doctor thinks the patient is not proper for this study.
5) Prognosis will be within 3 months.
6) Initial drainage worsen the status of the patient.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidekazu Mukai

Organization

Yodogawa Christian Hospital

Division name

Department of Gastroenterology

Zip code


Address

Awaji 2-9-26, Higashiyodogawa-Ku, Osaka

TEL

06-6322-2250

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kiyohito Tanaka

Organization

Kyoto Second Red Cross Hospital

Division name

Department of Gastoroenterology

Zip code


Address


TEL

075-231-5171

Homepage URL


Email



Sponsor or person

Institute

Kansai Endoscopic Device Selection (EDS) Working Group

Institute

Department

Personal name



Funding Source

Organization

Kansai Endoscopic Device Selection (EDS) Working Group

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 01 Month 14 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://www.nature.com/ajg/journal/v108/n11/full/ajg2013305a.html

Number of participants that the trial has enrolled


Results

Patient survival time in the two groups did not signifi cantly differ (median: 285 and 223 days,
respectively; P = 0.68). Patient survival time without stent dysfunction was signifi cantly longer
in the covered than in the uncovered SEMS group (median: 187 vs. 132 days; P = 0.043).Stent patency was also signifi cantly longer in the covered than in the uncovered SEMS group
(mean +- s.d.: 219.3 +- 159.1 vs. 166.9 +- 124.9 days; P = 0.047).Rates of tumor overgrowth and sludge formation did not signifi
cantly differ between the two groups, whereas the rate of tumor ingrowth was signifi cantly lower
in the covered than in the uncovered SEMS group ( P < 0.01).There was no signifi cant difference between
the two groups in the incidence of serious adverse events.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 02 Month 15 Day

Date of IRB


Anticipated trial start date

2009 Year 04 Month 01 Day

Last follow-up date

2011 Year 09 Month 01 Day

Date of closure to data entry

2011 Year 12 Month 24 Day

Date trial data considered complete

2012 Year 02 Month 25 Day

Date analysis concluded

2012 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 01 Month 14 Day

Last modified on

2014 Year 02 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002157